
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.17399</article-id>
<title-group>
<article-title>INTEGRATED AYURVEDIC APPROACH TO DANTAVESHTA (PERIODONTITIS): A CLINICAL EVALUATION
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>Roshni Patel *</name>
</contrib>
<contrib contrib-type='author'>
<name> Kundan Patel</name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>59</fpage>
<lpage>64</lpage>
<abstract><title>Abstract</title>
Introduction: Dantaveshta is classified as a Dantamoolagata Roga (disease of the tooth supporting structures). It is characterised by Dantamoolagata Raktasrava (blood discharge from gums), Puyasrava (Pus discharge from gums) and Chaladanta (tooth mobility). Raktadushti and Samanya Mukharoga Nidana are causative factors of Dantaveshta. In Allopathy science, Dantaveshta can be correlated with chronic periodontitis, an inflammatory disease caused by specific microorganisms that destroy the periodontal ligament and alveolar bone. Material __ampersandsign Method: An open-label, randomised, comparative clinical study was conducted in which 30 patients diagnosed with Dantaveshta were randomly allocated into two groups. Group A received Prachchhana Karma, Lodhradi Pratisarana, and Chandanandi Kwatha orally, while Group B received Prachchhana Karma and Lodhradi Pratisarana alone. Assessment was done using subjective parameters and objective periodontal indices. Result: The treatment was effective for most patients, showing marked to moderate improvement. Both groups showed statistically significant improvement in major clinical parameters; however, Group A demonstrated superior outcomes in gingival bleeding, pocket depth, and overall periodontal indices. Conclusion: Raktamokshana followed by Lodhradi Pratisarana, along with the oral adjuvant Chandanandi Kwatha, enhanced the therapeutic outcomes.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Dantaveshta</kwd>
<kwd> Raktamokshana</kwd>
<kwd> Pratisarana</kwd>
<kwd> Periodontitis.  </kwd>
</kwd-group>
<counts><ref-count count='0'/><page-count count='7'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
